Zobrazeno 1 - 10
of 10
pro vyhledávání: '"O. De Juan Viladegut"'
Autor:
O. De Juan Viladegut, H. Andreu Gracia, L. Bueno Sanya, L. Olivier Mayorga, E. Cesari, J. I. Mena, I. Ochandiano, S. Salmeron, L. Miquel
Publikováno v:
European Psychiatry, Vol 67, Pp S353-S353 (2024)
Introduction Chemsex refers to the use of drugs, typically stimulants and/or psychoactive substances, in a sexual context, often in the context of casual or group sex encounters. Currently, the practice of chemsex focuses on men who have sex with men
Externí odkaz:
https://doaj.org/article/6c8c34b7858f4f5cb8f2964b6698451e
Autor:
L. Bueno Sanya, O. De Juan Viladegut, L. Olivier Mayorga, H. Andreu Gracia, P. Barrio Giménez
Publikováno v:
European Psychiatry, Vol 67, Pp S404-S404 (2024)
Introduction In recent years, interest has grown in understanding the particularities of addiction in women. One of these singularities, with an important impact on public health, is pregnancy. Substance use during pregnancy has increased in recent d
Externí odkaz:
https://doaj.org/article/0aa3b30454064e3dade05f81efa3130d
Publikováno v:
European Psychiatry, Vol 66, Pp S1066-S1067 (2023)
Introduction Catatonia is a syndrome characterized by physical symptoms ranging from immobility to excessive motor activity. Besides being historically associated mainly with schizophrenia, it is widely known that it can be the expression of differen
Externí odkaz:
https://doaj.org/article/a6d9ef0ba51a460ea3ff2b73c8de0b86
Autor:
O. De Juan Viladegut, M. Llobet Farré, H. Andreu Gracia, L. Bueno Sanya, L. Olivier Mayorga, A. Morer Liñan, L. Lázaro García, A. E. Ortiz García
Publikováno v:
European Psychiatry, Vol 66, Pp S395-S395 (2023)
Introduction Prader-Willi syndrome (PWS) is a genetic disorder with an estimated prevalence of 1:25,000. PWS results from defective gene expression on the paternal copy of chromosome 15. In 70% of the cases it is a deletion that means that part of th
Externí odkaz:
https://doaj.org/article/ca67c5112d404b1aa2ad2260488b7cff
Autor:
L. Bueno Sanya, A. Bermejo Pastor, H. Andreu Gracia, O. De Juan Viladegut, L. Olivier Mayorga, I. Pacchiarotti
Publikováno v:
European Psychiatry, Vol 65, Pp S411-S412 (2022)
Introduction Pramipexole is a dopaminergic agonist used in the treatment of Parkinson’s disease and restless leg syndrome. Although there is a lack of pharmacological options to treat drug-induced parkinsonism, not many studies have been made on th
Externí odkaz:
https://doaj.org/article/b3f8c0c28d8c4c10a6a9f98c71c35074
Autor:
O. De Juan Viladegut, M. Bioque, L. Ilzarbe, H. Andreu Gracia, L. Bueno Sanya, L. Olivier Mayorga
Publikováno v:
European Psychiatry, Vol 65, Pp S587-S588 (2022)
Introduction Neuroleptic malignant syndrome (NMS) may be a life-threatening neurologic crisis primarily emerging as an idiosyncratic reaction to antipsychotic agent use, and characterized by a particular clinical syndrome of mental status alter, rigi
Externí odkaz:
https://doaj.org/article/fb5e646df8194f32927014982b5e33be
Autor:
H. Andreu Gracia, L. Ilzarbe, O. Marco Estrada, L. Bueno Sanya, O. De Juan Viladegut, L. Olivier Mayorga, L. Pintor, F. Valldeoriola, I. Grande
Publikováno v:
European Psychiatry, Vol 65, Pp S480-S480 (2022)
Introduction Bipolar disorder (BD) is considered a risk factor for developing Parkinson’s Disease (PD) because of an altered dopamine activity in both entities. Comorbidity may delay diagnosis and difficult therapeutic management. Objectives To de
Externí odkaz:
https://doaj.org/article/718b0ecceb6c4a83a792af8cf399c1c5
Publikováno v:
European Psychiatry, Vol 65, Pp S880-S880 (2022)
Introduction Stress is part of the daily life of many people, especially in Western countries. Recent studies have shown that cortisol has been listed as the primary hormone linked to stress. Currently, to measure cortisol values there are only tests
Externí odkaz:
https://doaj.org/article/8e2818f3b0564ffb8c83fc11b23e02ea
Autor:
L. Olivier Mayorga, L. Ilzarbe, H. Andreu Gracia, L. Bueno Sanya, O. De Juan Viladegut, P. Barrio
Publikováno v:
European Psychiatry, Vol 65, Pp S407-S407 (2022)
Introduction Use of Monoamine Oxidase Inhibitors (MAOIs) has experimented an important reduction in recent years, being replaced by other antidepressant drugs (ADs) associated with a better safety profile. Its use has been restricted to instructed pr
Externí odkaz:
https://doaj.org/article/2d0493d76f8941e3a5b92d682483a019
The role of cannabis in bipolar disorder relapse: a prospective study of hospital acute readmissions
Autor:
L. Olivier, A. Giménez, H. Andreu Gracia, L. Bueno, Ó. De Juan Viladegut, T. M. Fernández, I. Ochandiano, S. Salmerón, L. Bracco, L. Tardón Senabre, I. Pacchiarotti
Publikováno v:
European Psychiatry, Vol 67, Pp S437-S437 (2024)
Introduction With the rapid changes of attitude, investigation and legislation around cannabis and its subproducts in the Western world, there is a need to profoundly examine the consequences of its use in the general population and, specifically, in
Externí odkaz:
https://doaj.org/article/04ffcfd5e5d04038a19d541e8c48e5e1